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Heroin dependents might be at a higher risk of death from cancer than the 
general population. A 31-year-old male on maintenance treatment with 
Buprenorphine, came to our Clinic with paralysis of his legs. He also 
complained on spinal pains. He couldn’t walk and he was in forced position. 
The biochemical analysis showed high values of SE, LDH, globulins, CRP, 
D-dimer, Tu markers: beta HCG, CYFRA 21-1, presence of paraproteins. The 
other investigations showed enlarged lymph nodes in the abdomen and 
small pelvis, thrombosis of v.cava inf and right v. iliaca. The histological 
finding from the biopsy of the sacrum showed a metastatic process on the 
skeletal muscles. The patient was treated with buprenorphine, antibiotic 
therapy, Carbamazepine, anticoagulant therapy and other symtomatic 
therapy. Despite numerous investigations and treatment, bleeding and 
abscesses in the cerebrum occurred. The patient immediately underwent 
surgery and his recovery was well. He was discharged on his request, but 
his condition was deteriorated sharply at home and he died in a short time. 
There are few studies on malignant diseases found in heroin dependents. It 
is a challenge to monitor and also to compare the incidence of malignancy 
between heroin dependents and healthy population. 
 





Some drugs may be linked to cancer as many drugs 
cause cellular damage in the body.  Heroin dependents 
might be at a higher risk of death from cancer than the 
general population. Most experts recommend the most 
effective approach for cancer prevention, and that is a 
healthy lifestyle without smoking and drug use (Stop 
Addiction Blog. The link between Drug Use and Cancer, 
2013). Effects of heroin on the immune system may be in 
the form of immunosuppression (frequent infections and 
neoplasms) and in the form of immunostimulating 
(hypersensitivity and autoimmune reaction) (Luster and 
Rosenthal, 1993; Novick et al., 1991). 
Dependent opioid users, especially those injecting 
heroin, have increased somatic
 
and psychological 
morbidity and reduced health-related quality of life. 
Opioid dependence is associated with social 
marginalisation, criminality and socioeconomic 
deprivation accompanied by malnutrition, chronic 
diseases and generally impaired health as well as 
exposure to overdoses and trauma.
 
Mortality among 
injecting drug users is much greater than in the general 
population. The main causes of death (in descending 
order) are overdose, diseases, trauma and suicide. Few 
studies have investigated opioid maintenance treatment 
(OMT)-related somatic health effects and morbidity 
patterns. Drug-related incidents were reduced by about 
two thirds, but non-drug-related incidents showed a non-
significant increase (possibly due to closer contact with 
health services) and injuries showed no change during 
treatment. These  findings  were, however,  based upon a  




small sample of patients from one municipality. In order 
to evaluate the effects of maintenance treatment, it is 
necessary to study morbidity prior to, during and after 
OMT. Such studies are scarce, and very few include 
long-term follow-up. Opioid dependents  suffer increased 
health problems and reduced health- related quality of life 
as well as increased mortality, compared to the general 
population. In spite of the considerable morbidity, drug 
users frequently neglect their health problems, and 





We present a case of a 31-year-old male on treatment 
with Buprenorphine. When he came to our Clinic he told 
us that the while he was in prison, two months ago he 
had pain in his spine. Two weeks after he was released 
from prison he experienced swelling in his legs and 
genital area. There was no precise medical evidence, but 
as he told us the doctors from another hospital made 
investigations and they treated him with anticoagulant 
therapy, analgesics and antibiotics. His condition was 
ameliorated, but after one week he had the previous 
symptoms and pains. When he was admitted to the 
University Clinic of Toxicology in Skopje he complained 
on paralysis of his legs and on a large swelling on his 
right leg and genital area. He also complained on pains in 
his spine. He has never used heroin intravenously in the 
past, but he has abused cannabis several times. He 
began with heroin use when he was 24 years old. Almost 
3 years he was on maintenance treatment with 
Buprenorphine 8mg. The patient was conscious, afebrile, 
with poor subcutaneous fat, the skin was pale with visible 
distinct chest veins, palpabile inguinal lymph glands, 
large swelling on his right leg and on the genital area. He 
couldn’t walk and he was in forced position. 
Laboratory tests showed normal findings except for 
high sedimentation values: 108.. 120 (ref.val.: 4-10 
mm/1h)), lactate dehydrogenase: 2141.. 2827.. 3144.. 
4721.. 5678.. 6059 (ref.val.:up to 248 U/L), total proteins, 
particularly globulins: 55 (ref.val:27-35g/l), C-reactive 
protein: 114,7 (ref.val: up to 6mg/l). Electrophoresis 
detected paraprotein, especially increased gamma 
globulin fraction.  Bence-Jones proteinuria was negative. 
He was serologically negative on hepatitis B, C and HIV. 
Toxicological tests were negative for methadone, opiates, 
benzodiazepines, and positive for buprenorphine. 
Peripheral smear test showed neutrophils with toxic 
granules. Fibrin degradation products showed secondary 
activated fibrinolysis and high level of D-dimer: 2629.. 
4500 ng /ml. Microbiological finding of urine was sterile. 
Tumor markers showed high values of beta 
HCG:161112,68 (ref.val up to 3,0U/L), CYFRA 21-1: 
24,98 (ref. Val: up to 3,3µg/l) and the other Tu markers 
(CEA, AFP, CA19-9, CA72-4, PSA, PAP) were with 





the first ultrasonographic examination of the abdomen the 
liver was diffusely enlarged and the other organs were 
with normal ultrasonography findings. There were also 
several enlarged lymph glands around the blood vessels 
in the small pelvis, epigastric region and retroperitoneal 
enlarged lymph glands. Ultrasonographic examination of 
the testicles: right testicle slightly smaller 27 / 16 mm, 
homogeneous parenchyma without Tu formations. The 
left testis with dimension of 37 / 18 mm, had free liquid, 
thickened epididymis 11.2 mm. This finding was with 
differential diagnosis of epididymitis or orchitis. On 
Abdominal Color Doppler ultrasonography, v. cava 
inferior in subhepatic segment was with normal signal 
while in distal segment there was no signal. The left v. 
iliaca was with normal Color Doppler signal, but on the 
right v. iliaca there was thrombus.  Collor Dopler imaging 
of the lower extremities showed phlebothrombosis of the 
right v. ileofemoralis. Echocardiography showed mild 
regurgitation of the mitral and tricuspid valve, without 
vegetation and  any signs of pulmonary 
thromboembolism. Chest X-ray was with normal finding. 
During hospitalization the pain in his spine has 
become stronger. The pain was evaluated according to 
Pain Assessment Scale (Pain Assessment Scales. 
National Initiative of Pain Control, 2003).   X-ray of the 
thoracic and lumbal spine showed dextroconvex 
deviation and reduced lumbar lordosis. On the bone scan 
(skeletal scintigraphy with technetium 99MDP) performed 
in forced positions, there was no detection of pathological 
accumulations on skeleton. Multidetector computed 
tomography (MDCT) of the abdomen and pelvis  in a 
series with intravenous contrast showed that  liver, 
spleen, gall bladder, biliary tract, kidneys, adrenal glands 
and pancreas were without pathological lesions. Below 
the renal arteries there were visible enlarged lymph 
nodes, especially in the area of aortic bifurcation. 
Enlarged lymph glands were seen in the small pelvis. 
Other investigations with MNR of the distal part of the 
abdomen and small pelvis were (Figures 1-6). Magnetic 
resonance of the pelvis was made in forced position of 
the patient, only in one sequence. It detected thrombosis 
of the vena cava (the intraluminal clot reached the height 
of the distal renal veins and got into both iliac veins to the 
inguinal region). Osteolysis at the sacrum level S1 was 
also detected; the body of the sacrum was with lytic 
lesions predominantly on the right side and the process 
extended to the sacroiliac joint. There was substrate in 
the spinal canal. The magnetic resonance also showed 
increased retroperitoneal and paraaortal lymph glands. 
This investigation led to differential diagnosis between 
systemic disease and primary lesion of the sacrum, 
osteosarcoma. CT arteriography (phlebography) of the 
abdomen and the lower limbs showed that there was no 
compromising of the arterial circulation in aorta, iliac 
arteries, femoral arteries and a. poplitea. Clot filling was 
predominant in v. cava inferior, which  started at 5cm 
below renal veins and continued to the bifurcation  and  in  






Figure 1. CT of the abdomen, postcontrast series, arterial phase, section at kidneys 
height. Paraaortal on the left side, package of enlarged lymph nodes (arrow) with a 





Figure 2. CT of the abdomen, postcontrast series, venous phase, section at height 
below the renal lodges. Vena cava inferior (VCI) is with expanded lumen and visible 











Figure 3. CT of the abdomen, postcontrast series, venous phase, section at height of 
the entrance to the small pelvis. Clear display of the iliac veins (arrow), the right vein 
is with wider lumen and with visible intraluminal thrombotic masses. Right lateral 
mass of sacrum is structurally modified with osteolytic changes and soft tissue 





Figure 4. CT of the abdomen, postcontrast series, late phase, section at the kidneys 
height. Clear display of the left renal vein. In the lumen of the vein there is a filling 
oval defect - intraluminal clot (arrow). 
 
 






Figure  5. CT of the abdomen, postcontrast series, late phase, section at the height of 
the small pelvis. Clear display of the right external iliac vein which is with expanded 
lumen and visible thrombotic masses in the lumen (arrow). Enlarged lymph nodes in 





Figure 6. CT of the abdomen, postcontrast series, late phase, section at the height of 
the hips. Clear display on the right common femoral vein, which is with expanded 
lumen with intraluminal thrombotic masses (arrow). Increased number of lymph nodes 
perirectal and in the small pelvis. Also, on both sides of the inguinal region there are 
enlarged lymph nodes (triangles). 
 
 
the right iliac vein, right femoral vein and v. saphena 
several cm below the inguinal region. In the distal 
segments there was no thrombosis of the venous 
circulation. The  clot  in  the left iliac vein was about 4 to 5  




cm  long without compromising the distal segments of the 
femoral vein. There was a small recanalization clot in the 
middle of the left renal vein and the kidney was with 
normal findings. The investigation also showed enlarged 
inguinal, retroperitoneal, paraaortal, paracaval lymph 
nodes of 1-3 cm dimension. One of the lymph node was 
with central necrosis. There was osteolysis and 
destruction with osteosclerosis on the sacrum S1 and S2 
segment at the right side. According to the size of the 
lymph nodes one of the differential diagnoses could be 
lymphoma. The magnetic resonance of the lumbosacral 
spine involving the thoracic part Th11 and Th12 to the 
level of the sacral part showed advanced bone 
destruction of sacrum from S1 to S4. The substrate filled 
the spinal canal from vertebrae L4 to L5 and 
compromised the nerve roots from L3 and L4 on the right 
side and the nerve root of L5 bilaterally. The finding 
showed differential diagnosis of neoinfiltrative process or 
lymphoma or secondary deposits.  
During hospitalization inguinal lymph gland was 
extirpated by a plastic surgeon. Histological findings were 
dermatopathic lymphadenitis. Immunohistochemical 
analysis of the lymph gland indicated that it could be 
dermatopathic lymphadenitis or a part of tumor vascular 
proliferation that need further clinical investigations. 
During hospitalization the following specialists were 
consulted:  hematologist, anesthesiologist (Center for 
Pain), psychiatrist for the dependence problem, 
oncologist, pulmonologist, rheumatologist, digestive 
surgeon, gastroenterologist, urologist, plastic surgeon, 
specialist in transfusion medicine, cardiologist, orthopedic 
surgeon. 
Despite a number of investigations there was no 
precise diagnosis, and it was unclear whether it was 
lymphoma, osteosarcoma, systemic disease or some 
specific process was ongoing. So we planned to do a 
biopsy of the sacrum. But 20 days after hospitalization, 
the condition of the patient deteriorated and he began to 
lose consciousness. A neurosurgeon was immediately 
consulted and computer tomography of the brain was 
made. The computer tomography of the brain showed 
subcortical in parietal-occipital region clearly limited 
hyperdense lesion, intracerebral hemorrhage and 
compressive effect on the central brain structures. There 
was no indication of traumatic injury. The patient 
immediately underwent surgery and histological 
diagnosis confirmed abscess and bleeding in the 
cerebrum.  Postoperative recovery went well. After 10 
days biopsy of the sacrum was done. Two days after 
biopsy the patient asked to be discharged from the 
hospital by signing his history. However, after 5 days his 
condition rapidly deteriorated at home, he lost 
consciousness and died in a short time (His mother gave 
us these data). The histological finding from the biopsy of 
the sacrum showed metastatic process on the skeletal 
muscles. Unfortunately, despite a number of 





During hospitalization the patient was treated with 
buprenorphine which dose was constantly increased to 
32 mg. Buprenorphine was first reduced and stopped 
when the patient showed consciousness disturbance. 
Antibiotic therapy (ceftriaxone 2g) was also given, along 
with vitamins B and C, magnesium, Carbamazepine 
2x400mg, analgesic agent (NSAIL), anticoagulant 
therapy (first he was treated with Clexane 
subcutaneously twice a day 2x40mg and after that he 
was given oral anticoagulant therapy - Sintrom which was 






The management of dependence in patients with 
advanced cancer can be time-consuming, labor-
intensive, and difficult. Some clinicians believe that it is 
not worth the effort, due in part to a failure to appreciate 
the deleterious impact of dependence on palliative care 
efforts and a view of dependence as intractable in any 
case. Indeed, it is possible that some clinicians perceive 
dependence not only fatalistically but, because of 
common misconceptions, believe that managing or 
attempting to decrease the patient's use of alcohol or 
illicit substances would be tantamount to depriving a 
dying patient of a source of pleasure. Managing 
dependence is an essential aspect of palliative care for 
chemically-dependent and patients with alcochol use 
disorder. The goal of such efforts is not complete 
abstinence, but exerting enough control over illicit drug 
and alcohol use to allow palliative care interventions to 
decrease suffering (Passik and Theobald, 2000). 
Randal and colleagues examined cancer mortality in 
a population-based cohort of opioid-dependent persons. 
They observed New South Wales opioid substitution 
therapy (OST) program registrants from 1985 to 2005 
(n=43,789) who were probabilistically linked to the 
National Death Index. Crude and standardised mortality 
rates and standardised mortality ratios (SMRs) were 
calculated. The crude cancer mortality rate increased 
from 4 to 65 deaths per 100,000 person-years (p trend 
<0.001). Overall, OST registrants were 1.7 times more 
likely to die of cancer than the general population. Site-
specific SMRs were significantly elevated for lung cancer 
(3.6, 95% CI 2.8–4.6), liver cancer (6.9, 95% CI 4.3–
10.5), and anogenital cancers (2.8, 95% CI 1.3–5.3), and 
significantly reduced for breast cancer (0.4, 95% CI 0.1–
0.9). They concluded that cancer is an increasingly 
important cause of death among OST registrants as they 
live longer with their dependency. The site-specific 
excess deaths suggest the role of tobacco, alcohol, and 
infection with hepatitis C and human papillomavirus 
(Randall et al., 2011). 
The most important use of heroin and other opioid is 





a standard component of the famous Brompton Cocktail. 
Initially this cocktail contained heroin or morphine, 
cocaine and sometimes small amounts of alcohol. A 
review was published in 1974 including 500 patients with 
advanced malignancy treated with oral heroin/cocaine 
mixture or with heroin injection if they were unable to take 
medicine by mouth (Carnwath and Smith, 2002). 
Degenhardt and colleagues examined changes in 
causes of death in a cohort treated for opioid 
dependence. There were 43 789 people in the cohort, 
with 412 216 person-years of follow-up. The proportion of 
the cohort aged 40+ years increased from 1% in 1985 to 
39% in 2005. Accidental opioid overdoses, suicides, 
transport accidents and violent deaths declined with age; 
deaths from cardiovascular disease, liver disease and 
cancer increased (Degenhardt et al., 2014). 
Many studies on mortality in heroin users report 
traditional mortality data, which does not account for age 
at death. To examine causes of premature death and 
years of potential life lost (YPLL) among heroin users, 
researchers assessed 581 ethnically diverse men who 
had been admitted to a compulsory drug treatment 
program in California for heroin-dependent criminal 
offenders. Subjects were evaluated every 10 years over 
33 years.  The leading causes of death were heroin 
overdose (17% of deaths), chronic liver disease (15%), 
cardiovascular disease (12%), cancer (11%), accidents 





Very often somatic comorbidities can occur in patients 
with opioid use disorder. None somatic problem should 
be neglected and should be followed in detail. There are 
few studies on malignancy in heroin users. It is a 
challenge to monitor and also to compare the incidence 
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